Company / Revenue
Sonoma Pharmaceuticals, Inc. Revenue History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$14.3M
FY2026
5-year range
$12.6M / $18.6M
FY2022-FY2026
Trend
+12.2%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $9M in FY2017 to $19M in FY2020.
Based on SEC 10-K filings.
$14M in FY2026 with a 5-year CAGR of -4.4%.
Improved from $13M to $14M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- -4.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.4%, indicating a declining trend.
- In FY2026, revenue increased 12.2% year-over-year.
- Peak revenue was recorded in FY2020.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $14.3M | +12.2% |
| FY2025 | $12.7M | -4.0% |
| FY2024 | $13.3M | +5.1% |
| FY2023 | $12.6M | -32.2% |
| FY2022 | $18.6M | +3.9% |
| FY2021 | $17.9M | -5.5% |
| FY2020 | $19.0M | +13.9% |
| FY2019 | $16.7M | +29.9% |
| FY2018 | $12.8M | +36.9% |
| FY2017 | $9.4M | -32.4% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026